The Indian pharmaceutical industry is a major manufacturer of cost-effective generic drugs and is set to become the leading exporter of generic pharmaceutical products. However, recently the Indian pharmaceutical industry has seen several landmark judgments which will have a far-reaching effect on Indian pharma players, as well as international pharma giants.
This website follows the relevant rules of the Bar Council of India. By clicking, “I Agree” below, the user acknowledges and confirms that the contents of website are meant to provide necessary information about the firm, LexOrbis and updates on relevant laws in India. The information provided herein is not legal advice, and the Firm disclaims all liability arising from reliance placed by the user on the information contained therein. The Firm has made all efforts to ensure the accuracy of the contents of this website. The user also confirms that there has been no advertisement, personal communication, solicitation, invitation or inducement of any sort whatsoever from the Firm or any of its members to solicit any work or advertise through this website.
Please read and accept this Website’s Terms of Use and Privacy Policy before accessing the same.